LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award, Leidos, $36,854,529

Key CONT_AWD_75N91022F00007_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 494 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91022F00007_7529_75N91019D00024_7529
At the source https://www.usaspending.gov/award/CONT_AWD_75N91022F00007_7529_75N91019D00024_7529
Observed 2026-09-05, version 1, retrieved 2026-09-05T00:54:37Z
Content hash a44e4f8917a52db3b6496a9d8a891bba5b934a15d898cdfd011993323e7ba1ca

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

VersionAmountChangeOccurredPublishedRetrievedHow it arrivedContent hash
1
current
$36,854,529first versionMarch 7, 2022April 29, 20252026-09-05T00:54:37Zhistorical sweepa44e4f8917a5

Archived copy

https://web.archive.org/web/20261011033427/https://www.usaspending.gov/award/CONT_AWD_75N91022F00007_7529_75N91019D00024_7529 captured by this system, October 11, 2026

What the amount is made of

6 recorded actions, so the amount is the award's current total across all of them. 2 of them obligated money. Measured 2026-10-12, when USAspending reported a total obligation of $36,854,529.

Action dateModificationTypeObligatedDescription as recorded
April 24, 2025P00005TERMINATE FOR CONVENIENCE (COMPLETE OR PARTIAL)no moneyEOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI
December 20, 2023P00004OTHER ADMINISTRATIVE ACTIONno moneyTHIS COVID TASK ORDER SUPPORTS NIAIDS NEED TO CONDUCT A TRIAL OF AN ADDITIONAL DOSE VACCINE TO EVALUATE VARIANT VACCINES ALONE OR IN COMBINATION IN AN IMMUNOLOGICALLY DIVERSE POPULATION. THE WORK INCLUDES THE ABILITY TO PROVIDE THE MANAGEMENT, OVERS
May 16, 2023P00003OTHER ADMINISTRATIVE ACTIONno moneyTHIS COVID TASK ORDER SUPPORTS NIAIDS NEED TO CONDUCT A TRIAL OF AN ADDITIONAL DOSE VACCINE TO EVALUATE VARIANT VACCINES ALONE OR IN COMBINATION IN AN IMMUNOLOGICALLY DIVERSE POPULATION. THE WORK INCLUDES THE ABILITY TO PROVIDE THE MANAGEMENT, OVERS
December 14, 2022P00002OTHER ADMINISTRATIVE ACTIONno moneyTHIS COVID TASK ORDER SUPPORTS NIAIDS NEED TO CONDUCT A TRIAL OF AN ADDITIONAL DOSE VACCINE TO EVALUATE VARIANT VACCINES ALONE OR IN COMBINATION IN AN IMMUNOLOGICALLY DIVERSE POPULATION. THE WORK INCLUDES THE ABILITY TO PROVIDE THE MANAGEMENT, OVERS
July 28, 2022P00001DEFINITIZE LETTER CONTRACT+$14,653,976THIS COVID TASK ORDER SUPPORTS NIAIDS NEED TO CONDUCT A TRIAL OF AN ADDITIONAL DOSE VACCINE TO EVALUATE VARIANT VACCINES ALONE OR IN COMBINATION IN AN IMMUNOLOGICALLY DIVERSE POPULATION. THE WORK INCLUDES THE ABILITY TO PROVIDE THE MANAGEMENT, OVERS
March 7, 2022basenot on file+$22,200,553THIS COVID TASK ORDER SUPPORTS NIAIDS NEED TO CONDUCT A TRIAL OF AN ADDITIONAL DOSE VACCINE TO EVALUATE VARIANT VACCINES ALONE OR IN COMBINATION IN AN IMMUNOLOGICALLY DIVERSE POPULATION. THE WORK INCLUDES THE ABILITY TO PROVIDE THE MANAGEMENT, OVERS

Last refreshed November 4, 2026 at 2:31 PM UTC.